US agency faces petition to re-draw regulations on laboratory testing
This article was originally published in Clinica
A coalition of medical device industry associations in the US has filed a citizen petition asking the federal government to rethink the way it regulates laboratory testing under the 1988 Clinical Laboratories Improvement Act (CLIA).
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.